Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid

Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis

(2010) Laura Piccio et al.   ARCHIVES OF NEUROLOGY

Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis

(2010) F. Piazza et al.   JOURNAL OF NEUROIMMUNOLOGY

Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation

(2010) Barbara Serafini et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

B-CELL ACTIVATING FACTOR OF THE TNF FAMILY IS UPREGULATED IN NEUROMYELITIS OPTICA

(2010) K. Okada et al.   NEUROLOGY

Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid

(2009) Gregory P. Owens et al.   ANNALS OF NEUROLOGY

The Discovery of Oligoclonal Bands: A 50-Year Anniversary

(2009) Trygve Holmøy   EUROPEAN NEUROLOGY

Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia

(2009) Kwang Soo Kim et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor

(2009) L. Zhang et al.   JOURNAL OF NEUROSCIENCE

Serum levels of CXCL13 are elevated in active multiple sclerosis

(2009) Eugene D Festa et al.   Multiple Sclerosis Journal

Gaining entry to an uninflamed brain

(2009) Robert C Axtell et al.   NATURE IMMUNOLOGY

Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

(2009) F. Sellebjerg et al.   NEUROLOGY

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

(2008) Amit Bar-Or et al.   ANNALS OF NEUROLOGY

A Potential Role for B-Cell Activating Factor in the Pathogenesis of Autoimmune Myasthenia Gravis

(2008) Samia Ragheb et al.   ARCHIVES OF NEUROLOGY

BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells

(2008) G. Badr et al.   BLOOD

Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

(2008) M. Krumbholz et al.   BRAIN

B-lymphocyte contributions to human autoimmune disease

(2008) Koichi Yanaba et al.   IMMUNOLOGICAL REVIEWS

BAFF is a Biological Response Marker to IFN-β Treatment in Multiple Sclerosis

(2008) Kaushal S. Gandhi et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Autoantibodies and neurodegeneration in multiple sclerosis

(2008) Tamara Vyshkina et al.   LABORATORY INVESTIGATION

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine

(2008) Xiaochang Xue et al.   VACCINE